Zealand Pharma
688
DKK
-2.76 %
ZEAL
NASDAQ Copenhagen
Biotechnology & Pharmaceuticals
Health Care
Less than 1K followers
-2.76%
-3.64%
-3.84%
-18.05%
-21.91%
+47.39%
+448.64%
+183.13%
+765.41%
Zealand Pharma is a biotechnology company. Particular focus is found in the development of drugs for the treatment of diabetes and various intestinal diseases. The company has a varied product portfolio with separate brands that are sold on a global level. The largest business is in the Nordic market. Zealand Pharma was founded in 1997 and is headquartered in Söborg, Denmark.
Read moreMarket cap
48.86B DKK
Turnover
131.48M DKK
Revenue
342.79M
EBIT %
-166.94 %
P/E
-
Dividend yield-%
-
Financial calendar
20.2
2025
Annual report '24
8.5
2025
Interim report Q1'25
14.8
2025
Interim report Q2'25
ShowingAll content types
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
Aktier i Vælten - Et tilbageblik på bevægelserne i OMXC25 i 2024, og nogle forudsigelser for 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools